Literature DB >> 2829003

Differential effects of mu and kappa opioid systems on motivational processes.

T S Shippenberg1, A Herz.   

Abstract

The role of multiple opioid receptor types in mediating the motivational properties of opioid agonists and antagonists was investigated by means of a place-preference conditioning procedure. Mu-agonists produced positive reinforcing effects in drug-naive animals whereas kappa agonists and the opioid antagonist, naloxone, were aversive. Chronic infusion of naloxone during conditioning, at a dose sufficient to block mu- but not kappa-receptors, antagonized the effects of both morphine and naloxone. This treatment did not alter the aversion produced by the kappa agonist, U69593. These data demonstrate that opioid reinforcement results from an activation of mu-receptors whereas aversive effects are produced by either an antagonist action at this receptor or an activation of kappa receptors. Such results indicate that mu and kappa opioid systems differentially modulate motivational processes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2829003

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


  68 in total

1.  Early role of the κ opioid receptor in ethanol-induced reinforcement.

Authors:  Ricardo Marcos Pautassi; Michael E Nizhnikov; Ma Belén Acevedo; Norman E Spear
Journal:  Physiol Behav       Date:  2012-01-11

2.  Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests.

Authors:  Peng Huang; Tatyana Yakovleva; Jane V Aldrich; Julia Tunis; Christopher Parry; Lee-Yuan Liu-Chen
Journal:  Neurosci Lett       Date:  2016-01-15       Impact factor: 3.046

Review 3.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

4.  Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.

Authors:  Emily Dziedowiec; Sunil U Nayak; Keenan S Gruver; Tyra Jennings; Christopher S Tallarida; Scott M Rawls
Journal:  Neuroscience       Date:  2018-06-27       Impact factor: 3.590

5.  Differential Roles of Accumbal GSK3β in Cocaine versus Morphine-Induced Place Preference, U50,488H-Induced Place Aversion, and Object Memory.

Authors:  Xiangdang Shi; Jeffrey L Barr; Eva von Weltin; Cassandra Wolsh; Ellen M Unterwald
Journal:  J Pharmacol Exp Ther       Date:  2019-08-16       Impact factor: 4.030

Review 6.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

Review 7.  Opioids and exercise. An update.

Authors:  G A Sforzo
Journal:  Sports Med       Date:  1989-02       Impact factor: 11.136

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

9.  Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.

Authors:  Antony D Abraham; Selena S Schattauer; Kathryn L Reichard; Joshua H Cohen; Harrison M Fontaine; Allisa J Song; Salina D Johnson; Benjamin B Land; Charles Chavkin
Journal:  J Neurosci       Date:  2018-08-03       Impact factor: 6.167

10.  Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.

Authors:  Chloe M Erikson; Gengze Wei; Brendan M Walker
Journal:  Neuropharmacology       Date:  2018-07-31       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.